Myocardial iron deposition in β-Thalassemia studied by magnetic resonance imaging

被引:32
作者
Mavrogeni, SI
Maris, T
Gouliamos, A
Vlahos, L
Kremastinos, DT
机构
[1] Onassis Cardiac Surg Ctr, Athens, Greece
[2] Areteion Hosp, Athens, Greece
来源
INTERNATIONAL JOURNAL OF CARDIAC IMAGING | 1998年 / 14卷 / 02期
关键词
beta-thalassemia; heart; iron overload; MRI;
D O I
10.1023/A:1005922016048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial iron deposition is a common finding in beta-thalassemia. The iron content of the myocardium was assessed using the T2 relaxation time of the heart. The T2 relaxation time of the liver and skeletal muscle was also assessed in order to study the relation of iron deposition between heart, liver and skeletal muscle. ECG gated spin echo images were obtained from thirty-eight consecutive adult thalassemic patients examined in an outpatient clinic, aged (x+/-SD) 25+/-6 years, using a 0.5 T system. Patients were divided into groups A and B, according to their average serum ferritin levels of the preceding five years (> or < 2000 ng/ml). Results were compared with nine controls, aged 24+/-7 years. Heart T2 relaxation time in the control group (x+/-SD)(48.3+/-5.5 msec) was higher compared to group A (28.4+/-6.7 msec, p<0.001) but not to group B (43.4+/-7.4 msec). The T2 relaxation time of the heart correlated positively with the T2 relaxation time of the liver (r=0.68, p<0.001) and negatively with ferritin levels (r=-0.67, p<0.001). There was no correlation with the T2 relaxation time of skeletal muscle. This study indicates that regularly transfused beta-thalassemia patients may present with a broad variation of heart iron deposition which, however, is related to serum ferritin levels.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 28 条
[1]   IRON STATE AND HEPATIC-DISEASE IN PATIENTS WITH THALASSEMIA MAJOR, TREATED WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINE [J].
ALDOURI, MA ;
WONKE, B ;
HOFFBRAND, AV ;
FLYNN, DM ;
LAULICHT, M ;
FENTON, LA ;
SCHEUER, PJ ;
KIBBLER, CC ;
ALLWOOD, CA ;
BROWN, D ;
THOMAS, HC .
JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (11) :1353-1359
[2]   EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR [J].
BRITTENHAM, GM ;
GRIFFITH, PM ;
NIENHUIS, AW ;
MCLAREN, CE ;
YOUNG, NS ;
TUCKER, EE ;
ALLEN, CJ ;
FARRELL, DE ;
HARRIS, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09) :567-573
[3]   IRON IN HEART - ETIOLOGY AND CLINICAL SIGNIFICANCE [J].
BUJA, LM ;
ROBERTS, WC .
AMERICAN JOURNAL OF MEDICINE, 1971, 51 (02) :209-&
[4]   SERUM FERRITIN FAILS TO INDICATE HEMOCHROMATOSIS - NOTHING GOLD CAN STAY [J].
CROSBY, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (06) :333-334
[5]  
DIXON RM, 1994, HEPATOLOGY, V19, P904, DOI 10.1002/hep.1840190416
[6]  
ENGLE MA, 1969, ANN NY ACAD SCI, V119, P694
[7]   MR RELAXATION-TIMES AND IRON CONTENT OF THALASSEMIC SPLEENS - AN INVITRO STUDY [J].
GOMORI, JM ;
GROSSMAN, RI ;
DROTT, HR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 150 (03) :567-569
[8]   HEPATIC IRON OVERLOAD - QUANTITATIVE MR IMAGING [J].
GOMORI, JM ;
HOREV, G ;
TAMARY, H ;
ZANDBACK, J ;
KORNREICH, L ;
ZAIZOV, R ;
FREUD, E ;
KRIEF, O ;
BENMEIER, J ;
ROTEM, H ;
KUSPET, M ;
ROSEN, P ;
RACHMILEWITZ, EA ;
LOEWENTHAL, E ;
GORODETSKY, R .
RADIOLOGY, 1991, 179 (02) :367-369
[9]  
GREEN R, 1977, BLOOD, V50, P545
[10]  
HOUANG MTW, 1979, LANCET, V1, P1322